Inici › Sobrepès › Texas › Austin
Assaigs clínics de Sobrepès a Austin, TX
18 estudis de Sobrepès busquen participants en centres de Austin i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 2
- Elligo Clinical Research Center /ID# 282166, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutantFase 3
- Texas Diabetes & Endocrinology, Austin
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
ReclutantFase 3
- IMA Clinical Research Austin, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
ReclutantFase 3
- Dell Children's Medical Center - PIN, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutantFase 3
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
ReclutantFase 3
- FutureSearch Trials of Neurology, Austin
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ReclutantFase 3
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutantFase 2
- IMA Clinical Research Austin, Austin
Semaglutide for Post-Smoking Cessation Weight Management
ReclutantFase 2Voluntaris sans benvinguts
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 3
- AURORA-1 Clinical Site, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ReclutantFase 3Voluntaris sans benvinguts
- ACCOMPLISH-2 Research Site, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutantFase 2
- IMA Clinical Research Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutantFase 3
- Elligo Clinical Research Center, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutantFase 3
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
ReclutantFase 1
- Elligo Clin Res Centre, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
ReclutantFase 1
- Corxel Investigational Site, Austin
Assaigs de Sobrepès en altres ciutats
- San Antonio, TX34 estudis
- Houston, TX33 estudis
- Chicago, IL28 estudis
- Orlando, FL27 estudis
- Las Vegas, NV23 estudis
- Miami, FL23 estudis
- Atlanta, GA20 estudis
- Dallas, TX20 estudis
- New York City, NY19 estudis
- Jacksonville, FL19 estudis
- Washington, DC19 estudis
- Baltimore, MD17 estudis
Altres estudis a Austin
- Càncer de pulmó de cèl·lules no petites30 estudis
- Càncer (tots els tipus)20 estudis
- Obesitat20 estudis
- Càncer metastàtic19 estudis
- Càncer colorrectal19 estudis
- Insuficiència cardíaca18 estudis
- Càncer de mama18 estudis
- Càncer d'ovari17 estudis
- Càncer d'endometri15 estudis
- Càncer de pròstata15 estudis
- Depressió14 estudis
- Càncer de mama triple negatiu13 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.